Story perspectives

Atorvastatin Recall: Hundreds of Thousands at Risk

11/4/2025

32 4

Summary

Story summary

Ascend Laboratories (the manufacturer) issued a recall of atorvastatin tablets, the generic Lipitor, affecting potentially hundreds of thousands of patients.
The recalled tablets, manufactured between November 2024 and September 2025, failed to dissolve properly.
The defect can reduce the drug’s effectiveness in lowering LDL cholesterol and raise cardiovascular risk.
Patients should not stop taking the medication without consulting a healthcare provider.

1 of 1

Story summary

Ascend Laboratories (the manufacturer) issued a recall of atorvastatin tablets, the generic Lipitor, affecting potentially hundreds of thousands of patients.
The recalled tablets, manufactured between November 2024 and September 2025, failed to dissolve properly.
The defect can reduce the drug’s effectiveness in lowering LDL cholesterol and raise cardiovascular risk.
Patients should not stop taking the medication without consulting a healthcare provider.